Uracil

Uracil

SCHEMBL28405698

COc1c[nH]c(=O)[nH]c1=O.O=c1cc[nH]c(=O)[nH]1

nearest known ligand 0.57

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CRBN Q96SW2 1/20 0.57
▸ ALDH1A1 P00352 4/20 0.40
▸ LMNA P02545 2/20 0.40
▸ ATAD2 Q6PL18 1/20 0.40
▸ MMP2 P08253 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ DPYD Q12882 2/20 0.37
▸ SMN1; SMN2 Q16637 2/20 0.37
▸ KDM4E B2RXH2 1/20 0.37
▸ HPGD P15428 1/20 0.37
▸ GAA P10253 1/20 0.36
▸ TP53 P04637 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ CYP19A1 P11511 1/20 0.36
▸ TSHR P16473 1/20 0.36
▸ THPO P40225 1/20 0.36
▸ MTOR P42345 1/20 0.36
▸ HTT P42858 1/20 0.36
▸ HBB P68871 1/20 0.36
▸ PMP22 Q01453 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL102177 0.86 ATAD2 (0.52) ALDH1A1LMNAATAD2KMT2ADPYD
Uracil SCHEMBL28750821 0.78 — —
Thymine SCHEMBL574783 0.77 ATAD2 (0.70) CRBNALDH1A1LMNAATAD2MMP2
Uracil SCHEMBL5089507 0.75 — —
Uracil SCHEMBL8235 0.75 — —
Uracil SCHEMBL11607890 0.75 — —
Uracil SCHEMBL3798527 0.75 CRBN (1.00) CRBNALDH1A1LMNAATAD2MMP2
Fluorouracil SCHEMBL16766745 0.74 ALDH1A1 (0.70) CRBNALDH1A1LMNAATAD2MMP2
5-Bromouracil SCHEMBL27980194 0.74 CRBN (0.63) CRBNALDH1A1LMNAATAD2MMP2
Uracil SCHEMBL28426792 0.73 CRBN (0.85) CRBNALDH1A1LMNAATAD2MMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117069785-A Lipid compounds and lipid nanoparticle compositions 中生复诺健生物科技(上海)有限公司 2023-11-17 — — CN disclosed
CN-111417622-A Sulfonamides and compositions thereof for the treatment of conditions associated with N L RP activity 诺华炎症研究公司 2020-07-14 — — CN disclosed
CN-111094243-A Compounds and compositions for treating conditions associated with NLRP activity 诺华炎症研究公司 2020-05-01 — — CN disclosed
CN-111094242-A Compounds and compositions for treating conditions associated with NLRP activity 诺华炎症研究公司 2020-05-01 — — CN disclosed
Send feedback